Clinical Trial Update: MMP14(MT1-MMP) Targeting Bicyclic Peptide Probe for PET Imaging in Solid Tumors

View source ↗

Summary

A clinical trial registry entry describes a bicyclic peptide probe targeting MMP14 (MT1-MMP) for PET imaging in solid tumors, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• MMP14 MT1-MMP targeting bicyclic peptide PET imaging probe (MMP14 MT1-MMP targeted bicyclic peptide probe for PET imaging)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Solid Tumor | Status: NOT_YET_RECRUITING